BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

890 related articles for article (PubMed ID: 15719376)

  • 1. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
    Rorstad O
    J Surg Oncol; 2005 Mar; 89(3):151-60. PubMed ID: 15719376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical diagnosis of neuroendocrine GEP tumor.
    Oberg K
    Yale J Biol Med; 1997; 70(5-6):501-8. PubMed ID: 9825477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.
    Korse CM; Bonfrer JM; Aaronson NK; Hart AA; Taal BG
    Neuroendocrinology; 2009; 89(3):296-301. PubMed ID: 18840995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal carcinoid tumors.
    Eller R; Frazee R; Roberts J
    Am Surg; 1991 Jul; 57(7):434-7. PubMed ID: 2058850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome).
    de Herder WW
    Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):705-15. PubMed ID: 16253895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of CD44 expression in gastrointestinal neuroendocrine tumors.
    Lai CH; Shan YS; Sy ED; Hsieh YH; Tsai HW; Lee JC; Lin PW
    Hepatogastroenterology; 2005; 52(64):1071-6. PubMed ID: 16001632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical evaluation of 2001 carcinoid cases with metastases, collected from literature: a comparative study between ordinary carcinoids and atypical varieties.
    Soga J
    J Exp Clin Cancer Res; 1998 Mar; 17(1):3-12. PubMed ID: 9646227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of low-grade neuroendocrine tumors of midgut and unknown origin.
    Van Eeden S; Quaedvlieg PF; Taal BG; Offerhaus GJ; Lamers CB; Van Velthuysen ML
    Hum Pathol; 2002 Nov; 33(11):1126-32. PubMed ID: 12454818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surgical therapy of carcinoid tumors of the gastrointestinal tract].
    Böttger T
    Zentralbl Chir; 2001 Sep; 126(9):676-81. PubMed ID: 11699282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposed staging system for gastrointestinal carcinoid tumors.
    Landry CS; McMasters KM; Scoggins CR; Martin RC
    Am Surg; 2008 May; 74(5):418-22. PubMed ID: 18481499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchopulmonary carcinoid tumors--a significant diagnostic problem.
    Kedra P; Jeleń M; Szkudlarek-Gruszczyńska T; Leśkow E
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():146-61. PubMed ID: 9337533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization.
    Panzuto F; Nasoni S; Falconi M; Corleto VD; Capurso G; Cassetta S; Di Fonzo M; Tornatore V; Milione M; Angeletti S; Cattaruzza MS; Ziparo V; Bordi C; Pederzoli P; Delle Fave G
    Endocr Relat Cancer; 2005 Dec; 12(4):1083-92. PubMed ID: 16322345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of immunohistochemistry in gastric neuroendocrine (carcinoid) tumors.
    Safatle-Ribeiro AV; Ribeiro U; Corbett CE; Iriya K; Kobata CH; Sakai P; Yagi OK; Pinto PE; Zilberstein B; Gama-Rodrigues J
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):21-8. PubMed ID: 17206073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases.
    Soga J
    Cancer; 2005 Apr; 103(8):1587-95. PubMed ID: 15742328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic clinicopathologic factors in longitudinally followed patients with metastatic small bowel carcinoid tumors.
    Curran T; Tulin-Silver S; Patel K; Ward S; Schneiderman M; Harpaz N; Schwartz M; Itzkowitz S; Warner RR; Kim MK
    Pancreas; 2011 Nov; 40(8):1253-7. PubMed ID: 21975435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of proliferation markers in gastrointestinal carcinoid tumors: a clinicopathologic study.
    Sökmensüer C; Gedikoglu G; Uzunalimoglu B
    Hepatogastroenterology; 2001; 48(39):720-3. PubMed ID: 11462912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut-endocrinomas (carcinoids and related endocrine variants) of the uterine cervix: an analysis of 205 reported cases.
    Soga J; Osaka M; Yakuwa Y
    J Exp Clin Cancer Res; 2001 Sep; 20(3):327-34. PubMed ID: 11718210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal carcinoid tumours. Histogenetic, histochemical, immunohistochemical, clinical and therapeutic aspects.
    Wilander E; Lundqvist M; Oberg K
    Prog Histochem Cytochem; 1989; 19(2):1-88. PubMed ID: 2662260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of carcinoid tumors in the gastrointestinal tract].
    Nishikura K; Watanabe H; Iwafuchi M; Ajioka Y; Mukai G
    Gan To Kagaku Ryoho; 2003 May; 30(5):606-13. PubMed ID: 12795090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.